|
661
|
|
|
Anoctamin 2 |
C12orf3, TMEM16B |
|
|
662
|
|
|
AarF domain containing kinase 1 |
MCP2 |
|
|
663
|
|
|
ADAMTS like 3 |
ADAMTSL-3 |
Asthma, Obstructive pulmonary disease, Developmental dysplasia of the hip, Inflammatory bowel disease, Osteoarthritis, Peptic ulcer disease, Respiratory system disease, Schizophrenia, Scoliosis, Diabetes mellitus, type 2 |
|
664
|
|
|
ATPase phospholipid transporting 10A (putative) |
ATP10C, ATPVA, ATPVC |
|
|
665
|
|
|
ATPase phospholipid transporting 8B2 |
ATPID |
|
|
666
|
|
|
Adhesion G protein-coupled receptor G6 |
APG1, DREG, GPR126, LCCS9, PR126, PS1TP2, VIGR |
Arthrogryposis multiplex congenita, Central nervous system cancer, Obstructive pulmonary disease, Differentiated thyroid carcinoma, Endometriosis, Glioma, Hypertension, Inflammatory bowel disease, Intellectual developmental disorder, Lethal congenital contracture syndrome, Major depressive disorder, Peripheral arterial disease, Scoliosis, Diabetes mellitus, type 2 |
|
667
|
|
|
Activation induced cytidine deaminase |
AID, ARP2, CDA2, HEL-S-284, HIGM2 |
|
|
668
|
|
|
Arsenite methyltransferase |
CYT19 |
Alzheimer disease, Attention deficit hyperactivity disorder, Autism, Bipolar disorder, Coronary artery disease, Developmental disability, Insomnia, Diabetes mellitus, type 2, Lung neoplasms, Major depressive disorder, Obesity, Myocardial infarction, Neurotic disorder, Schizophrenia, Skin disease, Urinary bladder cancerView all (1 more) |
|
669
|
|
|
Aryl hydrocarbon receptor repressor |
AHH, AHHR, bHLHe77 |
|
|
670
|
|
|
AT-rich interaction domain 1B |
6A3-5, BAF250B, BRIGHT, CSS1, DAN15, ELD/OSA1, MRD12, OSA2, P250R, SMARCF2 |
Alzheimer disease, Asthma, Attention deficit hyperactivity disorder, Autism, Breast cancer, Hepatocellular carcinoma, Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay, Coffin-siris syndrome, Color vision deficiency, Desbuquois syndrome, Developmental disability, Epilepsy, Global developmental delay, Hypertrichosis, Intellectual developmental disorder, Neuroblastoma, Neurodevelopmental disorders, Pituitary stalk interruption syndrome, Psychiatric disorders, Schizophrenia, Severe combined immunodeficiency, Substance abuse, Diabetes mellitus, type 2, Wiedemann-steiner syndromeView all (9 more) |